EUROPEAN JOURNAL OF ENDOCRINOLOGY, cilt.186, sa.4, ss.417-427, 2022 (SCI-Expanded)
Objective: The phenotype mediated by HNF4A/HNF1A mutations is variable and includes diazoxide-responsive hyperinsulinaemic hypoglycaemia (HH) and maturity-onset diabetes of the young (MODY).